Glenmark Pharmaceuticals Ltd on Wednesday said its US arm has launched the generic version of Clindamycin Phosphate foam, an.

Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment.

This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured ...

Topical clindamycin is a first-line treatment for a severe type of acne that happens when bacteria clog pores and triggers ...

Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%: Our Bureau, Mumbai Wednesday, February 12, 2025, 12:30 Hrs [IST] Glenmark Pharmaceuticals Inc., USA ...

According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million ...

Products with topical or oral clindamycin are contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis (sanofi-aventis U.S. LLC ...

Clindamycin is a bitter-tasting antibiotic medication used by veterinarians to treat infections in both cats and dogs. Common ...

Clindamycin (as phosphate) 1%; lotion; gel. Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly ...